Track the IMU stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are quoted on AU AU, under the oversight of ASX. Operating in the Healthcare & Pharma sector, IMU has recorded 4 public disclosures. Market capitalisation: €44.6m. The latest transaction was filed on 6 July 2026 (Other). Among the most active insiders: Unknown. All data is free.
Analysts rate IMU Strong Buy (bullish), based on 3 analysts. Average price target: A$0.31.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
IMU is a company operating in the healthcare and pharmaceutical sector, listed on the XASX market.